Gumusoglu, Serena B. http://orcid.org/0000-0002-2098-388X
Kiel, Michaela D.
Gugel, Aleigha
Schickling, Brandon M.
Weaver, Kaylee R.
Lauffer, Marisol C.
Sullivan, Hannah R.
Coulter, Kaylie J.
Blaine, Brianna M.
Kamal, Mushroor
Zhang, Yuping
Devor, Eric J.
Santillan, Donna A.
Gantz, Stephanie C. http://orcid.org/0000-0002-1800-4400
Santillan, Mark K.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (5T32HL007121-45, T32 HL007344, HD089940, HD000849, RR024980, 3UL1TR002537, P50HD10355601A1)
American Heart Association (22POST30908921, 18SCG34350001, 19IPLOI34760288)
Iowa Medical Student Research Program Summer Fellowship
U.S. Department of Health & Human Services | National Institutes of Health
University of Iowa Summer Undergraduate Research Fellowship
Carver College of Medicine and Iowa Neuroscience Institute Carver Trust Early-Stage Investigator award
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 13 June 2023
Revised: 26 September 2023
Accepted: 28 September 2023
First Online: 17 October 2023
Competing interests
: MKS is a member of the Medical Advisory Board for Comanche Pharmaceuticals and EndPreeclampsia, LLC. DAS is a member of the Medical Advisory Board for EndPreeclampsia, LLC. DAS and MKS hold patents related to the prediction and treatment of preeclampsia: US 293 #9,937,182 (April 10, 2018), EU #2,954,324, and PCT/US2018/027152. All other authors report no competing interests.